• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新生血管性青光眼小梁切除术前玻璃体内注射贝伐单抗后的长期预后

Long-term Outcomes After Preoperative Intravitreal Injection of Bevacizumab Before Trabeculectomy for Neovascular Glaucoma.

作者信息

Kobayashi Satoshi, Inoue Maiko, Yamane Shin, Sakamaki Kentaro, Arakawa Akira, Kadonosono Kazuaki

机构信息

*Department of Ophthalmology, Yokohama Hodogaya Central Hospital Departments of †Ophthalmology ‡Biostatistics and Epidemiology, Yokohama City University Medical Center, Yokohama, Japan.

出版信息

J Glaucoma. 2016 Mar;25(3):281-4. doi: 10.1097/IJG.0000000000000211.

DOI:10.1097/IJG.0000000000000211
PMID:25580888
Abstract

PURPOSE

To evaluate the long-term (>3 y) outcomes of patients given preoperative intravitreal bevacizumab (IVB) injection before trabeculectomy for neovascular glaucoma (NVG).

METHOD

We performed a retrospective study of a consecutive series of 12 eyes of 11 patients who underwent trabeculectomy with mitomycin C combined with preoperative IVB for NVG at our institution between April 2009 and April 2010. The mean follow-up period was 43.0±7.0 months (range, 36 to 51 mo), and all patients were followed up for at least 36 months. Surgical success was defined as an intraocular pressure (IOP) of ≤21 mm Hg with or without topical ocular hypotensive medication.

RESULT

The cumulative surgical success rate was 83.3% at 1 year and 83.3% at 3 years. The mean IOP before surgery was 42.7±9.2 mm Hg, whereas the mean postoperative IOP was significantly lower, being 15.1±3.7 mm Hg at 1 year and 14.2±3.2 mm Hg at 3 years (P<0.01).In contrast, no significant change of the mean visual acuity as compared with the preoperative visual acuity was observed at the follow-up carried out 3 years after the surgery. Intraoperative and early postoperative hyphema was seen in 2 eyes. Recurrence of neovascularization requiring additional IVB injection was seen in 3 eyes.

CONCLUSIONS

Preoperative IVB injection before trabeculectomy for NVG might be effective over the long-term (>3 y) control of the IOP.

摘要

目的

评估在小梁切除术前行玻璃体内注射贝伐单抗(IVB)治疗新生血管性青光眼(NVG)患者的长期(>3年)疗效。

方法

我们对2009年4月至2010年4月期间在我院接受丝裂霉素C小梁切除术联合术前IVB治疗NVG的11例患者的12只眼睛进行了一项回顾性研究。平均随访期为43.0±7.0个月(范围36至51个月),所有患者均随访至少36个月。手术成功定义为眼压(IOP)≤21 mmHg,无论是否使用局部降眼压药物。

结果

1年时累积手术成功率为83.3%,3年时为83.3%。术前平均IOP为42.7±9.2 mmHg,而术后平均IOP显著降低,1年时为15.1±3.7 mmHg,3年时为14.2±3.2 mmHg(P<0.01)。相比之下,术后3年随访时,与术前视力相比,平均视力无显著变化。2只眼睛出现术中及术后早期前房积血。3只眼睛出现新生血管复发,需要再次注射IVB。

结论

小梁切除术治疗NVG术前注射IVB可能对长期(>3年)控制眼压有效。

相似文献

1
Long-term Outcomes After Preoperative Intravitreal Injection of Bevacizumab Before Trabeculectomy for Neovascular Glaucoma.新生血管性青光眼小梁切除术前玻璃体内注射贝伐单抗后的长期预后
J Glaucoma. 2016 Mar;25(3):281-4. doi: 10.1097/IJG.0000000000000211.
2
Combined intravitreal bevacizumab and trabeculectomy with mitomycin C versus trabeculectomy with mitomycin C alone for neovascular glaucoma.玻璃体内联合应用贝伐单抗和小梁切除术联合丝裂霉素 C 与单独小梁切除术联合丝裂霉素 C 治疗新生血管性青光眼。
J Glaucoma. 2011 Mar;20(3):196-201. doi: 10.1097/IJG.0b013e3181d9ce12.
3
Management of neovascular glaucoma with panretinal photocoagulation, intravitreal bevacizumab, and subsequent trabeculectomy with mitomycin C.全视网膜光凝、玻璃体内注射贝伐单抗联合随后的丝裂霉素 C 小梁切除术治疗新生血管性青光眼。
J Glaucoma. 2010 Dec;19(9):622-6. doi: 10.1097/IJG.0b013e3181ccb794.
4
Long-term results of Ahmed glaucoma valve in association with intravitreal bevacizumab in neovascular glaucoma.艾哈迈德青光眼引流阀联合玻璃体内注射贝伐单抗治疗新生血管性青光眼的长期疗效
J Glaucoma. 2015 Jun-Jul;24(5):383-8. doi: 10.1097/IJG.0000000000000234.
5
Hyphema is a risk factor for failure of trabeculectomy in neovascular glaucoma: a retrospective analysis.前房积血是新生血管性青光眼行小梁切除术失败的危险因素:回顾性分析。
BMC Ophthalmol. 2014 Apr 26;14:55. doi: 10.1186/1471-2415-14-55.
6
Surgical outcomes of intravitreal bevacizumab and guarded filtration surgery in neovascular glaucoma.抗血管内皮生长因子药物玻璃体腔内注射联合保守滤过手术治疗新生血管性青光眼的疗效观察。
J Glaucoma. 2010 Mar;19(3):212-8. doi: 10.1097/IJG.0b013e3181aae928.
7
Beneficial effects of preoperative intravitreal bevacizumab on trabeculectomy outcomes in neovascular glaucoma.新生血管性青光眼行小梁切除术前行玻璃体内注射贝伐单抗的疗效观察。
Acta Ophthalmol. 2010 Feb;88(1):96-102. doi: 10.1111/j.1755-3768.2009.01648.x. Epub 2009 Sep 23.
8
Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases.玻璃体内注射贝伐单抗治疗41例连续性缺血性视网膜疾病继发的虹膜新生血管和新生血管性青光眼。
Ophthalmology. 2008 Sep;115(9):1571-80, 1580.e1-3. doi: 10.1016/j.ophtha.2008.02.026. Epub 2008 Apr 28.
9
Surgical results of Ahmed valve implantation with intraoperative bevacizumab injection in patients with neovascular glaucoma.术中注射贝伐单抗的 Ahmed 阀植入术治疗新生血管性青光眼的手术效果。
J Glaucoma. 2012 Jun-Jul;21(5):331-6. doi: 10.1097/IJG.0b013e31820e2fd0.
10
Intracameral ranibizumab and subsequent mitomycin C augmented trabeculectomy in neovascular glaucoma.前房内雷珠单抗联合后续丝裂霉素 C 增强的小梁切除术治疗新生血管性青光眼。
J Glaucoma. 2014 Sep;23(7):437-40. doi: 10.1097/IJG.0b013e3182946398.

引用本文的文献

1
Surgical Outcomes of Mitomycin-C Augmented Trabeculectomy in Neovascular Glaucoma and Prognostic Factors for Surgical Failure in Thailand.泰国新生血管性青光眼患者丝裂霉素C辅助小梁切除术的手术结果及手术失败的预后因素
Clin Ophthalmol. 2024 Nov 1;18:3111-3123. doi: 10.2147/OPTH.S485331. eCollection 2024.
2
Neovascular Glaucoma Progress and Impact of Therapeutic Intervention in Saudi Arabia.沙特阿拉伯新生血管性青光眼的进展及治疗干预的影响
Cureus. 2021 Sep 3;13(9):e17696. doi: 10.7759/cureus.17696. eCollection 2021 Sep.
3
Role of bevacizumab intraocular injection in the management of neovascular glaucoma.
贝伐单抗眼内注射在新生血管性青光眼治疗中的作用
Int J Ophthalmol. 2021 Jun 18;14(6):855-859. doi: 10.18240/ijo.2021.06.10. eCollection 2021.
4
Surgical outcomes after primary Baerveldt glaucoma implant surgery with vitrectomy for neovascular glaucoma.新生血管性青光眼行玻璃体切割的原发性 Baerveldt 青光眼植入术后的手术结果。
PLoS One. 2021 Apr 15;16(4):e0249898. doi: 10.1371/journal.pone.0249898. eCollection 2021.
5
Postoperative adjunctive bevacizumab versus placebo in primary trabeculectomy surgery for glaucoma.青光眼原发性小梁切除术术后辅助使用贝伐单抗与安慰剂的对比研究
Int J Ophthalmol. 2019 Oct 18;12(10):1567-1574. doi: 10.18240/ijo.2019.10.08. eCollection 2019.
6
What is the impact of intravitreal injection of conbercept on neovascular glaucoma patients: a prospective, interventional case series study.玻璃体内注射康柏西普对新生血管性青光眼患者的影响:一项前瞻性、干预性病例系列研究。
BMC Ophthalmol. 2019 Jun 11;19(1):128. doi: 10.1186/s12886-019-1138-6.
7
Comparison of the safety and efficacy of triple sequential therapy and transscleral cyclophotocoagulation for neovascular glaucoma in the angle-closure stage.比较三联序贯疗法与经巩膜睫状体光凝术治疗闭角型新生血管性青光眼的安全性和疗效。
Sci Rep. 2018 May 4;8(1):7074. doi: 10.1038/s41598-018-25394-9.
8
Management of neovascular glaucoma with intravitreal ranibizumab, panretinal photocoagulation, and subsequent 5-fluorouracil augmented trabeculectomy: A case report.玻璃体内注射雷珠单抗、全视网膜光凝及后续5-氟尿嘧啶强化小梁切除术治疗新生血管性青光眼:一例报告
Medicine (Baltimore). 2017 Jun;96(25):e7221. doi: 10.1097/MD.0000000000007221.
9
Efficacy and safety of intravitreal ranibizumab with panretinal photocoagulation followed by trabeculectomy compared with Ahmed glaucoma valve implantation in neovascular glaucoma.玻璃体内注射雷珠单抗联合全视网膜光凝后行小梁切除术与艾哈迈德青光眼引流阀植入术治疗新生血管性青光眼的疗效和安全性比较
Int J Ophthalmol. 2017 Mar 18;10(3):400-405. doi: 10.18240/IJO.2017.03.12. eCollection 2017.
10
Neovascular glaucoma: a retrospective review from a tertiary center in China.新生血管性青光眼:来自中国一家三级中心的回顾性研究。
BMC Ophthalmol. 2016 Jan 27;16:14. doi: 10.1186/s12886-016-0190-8.